Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

478 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective.
Chiappini S, Guirguis A, Schifano N, Corkery JM, Semeraro F, Mosca A, D'Andrea G, Duccio Papanti G, Arillotta D, Floresta G, Martinotti G, Schifano F. Chiappini S, et al. Among authors: martinotti g. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Dec 6;136:111213. doi: 10.1016/j.pnpbp.2024.111213. Online ahead of print. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 39647692 Free article.
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis.
Guirguis A, Chiappini S, Papanti P GD, Vickers-Smith R, Harris D, Corkery JM, Arillotta D, Floresta G, Martinotti G, Schifano F. Guirguis A, et al. Among authors: martinotti g. Eur Neuropsychopharmacol. 2024 May;82:82-91. doi: 10.1016/j.euroneuro.2024.02.003. Epub 2024 Mar 19. Eur Neuropsychopharmacol. 2024. PMID: 38508100 Free article.
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward.
Chiappini S, Papanti Pelletier GD, Vickers-Smith R, Corkery JM, Guirguis A, Martinotti G, Schifano F. Chiappini S, et al. Among authors: martinotti g. Expert Opin Pharmacother. 2023 Sep-Dec;24(18):1915-1918. doi: 10.1080/14656566.2023.2271389. Epub 2024 Jan 5. Expert Opin Pharmacother. 2023. PMID: 37853742 No abstract available.
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia.
Selvaggi P, Fazio L, Toro VD, Mucci A, Rocca P, Martinotti G, Cascino G, Siracusano A, Zeppegno P, Pergola G, Bertolino A, Blasi G, Galderisi S; Italian Network for Research on Psychosis. Selvaggi P, et al. Among authors: martinotti g. Schizophr Res. 2023 Oct;260:76-84. doi: 10.1016/j.schres.2023.08.015. Epub 2023 Aug 24. Schizophr Res. 2023. PMID: 37633126 Free article.
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine.
Pettorruso M, d'Andrea G, Di Carlo F, De Risio L, Zoratto F, Miuli A, Benatti B, Vismara M, Pompili E, Nicolò G, Niolu C, Siracusano A, Sensi SS, Dell'Osso B, Di Lorenzo G, Martinotti G; ReModula Study Group. Pettorruso M, et al. Among authors: martinotti g. Brain Stimul. 2023 Jul-Aug;16(4):1041-1043. doi: 10.1016/j.brs.2023.06.003. Epub 2023 Jun 17. Brain Stimul. 2023. PMID: 37331507 Free article. No abstract available.
478 results